5:45 pm – 5:55 pm
Novartis Ballroom
Novartis Ballroom
By 2030, the global cancer burden is expected to grow to 22.2MillionCancer cases
Innovation Break: Announcing the C³ Prize from Astellas Oncology and the World Medical Innovation Forum
April 25, 2016 by 2012pharmaceutical
-
Recent Posts
- RNA from the SARS-CoV-2 virus taking over the cells it infects: Virulence – Pathogen’s ability to infect a Resistant Host: The Imbalance between Controlling virus Replication versus Activation of the Adaptive Immune Response May 23, 2020
- UPDATED Is Remdesivir the miracle cure or a short term cure for COVID-19? May 22, 2020
- Australian Children’s Hospital: SARS-CoV-2 Testing May 20, 2020
- A Series of Recently Published Papers Report the Development of SARS-CoV2 Neutralizing Antibodies and Passive Immunity toward COVID19 May 19, 2020
- The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Partnership on May 18, 2020 May 18, 2020
- Race to develop antibody drugs for COVID-19 May 18, 2020
- Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats May 17, 2020
- The COVID-19 Recovery will be digital: A plan for the First 90 Days May 16, 2020
- Crowdsourcing Difficult-to-Collect Epidemiological Data in Pandemics: Lessons from Ebola to the current COVID-19 Pandemic May 15, 2020
- The Seasonality of COVID-19 May 15, 2020
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
jshertok
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
ofermar2020
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
Leave a Reply